Medpace Holdings (MEDP) Gross Profit (2015 - 2026)

Medpace Holdings has reported Gross Profit for 12 years, with the latest figure at $196.3 million in Q1 2026.

• For the quarter ending Q1 2026, Gross Profit rose 10.08% year-over-year to $196.3 million; the trailing twelve-month figure through Mar 2026 stood at $778.6 million (up 14.58% YoY), and the FY2025 full-year result was $760.6 million, up 15.89% from the prior year.
• Gross Profit for Q1 2026 stood at $196.3 million, down from $205.3 million in the prior quarter.
• The five-year high for Gross Profit was $205.3 million in Q4 2025, with the low at $98.7 million in Q1 2022.
• Historically, Gross Profit has averaged $151.2 million across 5 years, with a median of $153.8 million in 2024.
• Annual changes were most pronounced in 2022 — Gross Profit surged 36.67% — and 2026, when it gained 10.08%.
• Medpace Holdings' Gross Profit stood at $115.7 million in 2022, then increased by 18.21% to $136.8 million in 2023, then surged by 30.34% to $178.3 million in 2024, then gained by 15.14% to $205.3 million in 2025, then dropped by 4.38% to $196.3 million in 2026.
• The last three Gross Profit figures came in at $196.3 million (Q1 2026), $205.3 million (Q4 2025), and $196.9 million (Q3 2025), per Business Quant data.